Journal Aims and Scope
The Journal of Immunology Research and Vaccines is dedicated to advancing the science of immunology, vaccine development, and immune-based therapies through the publication of high-quality, peer-reviewed research. The journal serves as a key resource for scientists, clinicians, and public health professionals involved in the study of the immune system and its role in combating infectious diseases, cancers, autoimmune disorders, and other health challenges.
Aims:
-
To advance immunological knowledge: We aim to publish groundbreaking research that deepens our understanding of immune responses in both health and disease, with a focus on mechanisms underlying immunity, tolerance, and inflammation.
-
To support vaccine development: Our goal is to foster the development of novel vaccines and immunotherapies by highlighting innovative approaches, new technologies, and emerging strategies for preventing and treating infectious diseases, cancer, and other immune-related conditions.
-
To bridge basic science and clinical applications: We seek to publish studies that translate immunological discoveries into clinical innovations, improving the effectiveness of vaccines and immune therapies in diverse populations.
-
To provide a platform for multidisciplinary research: We welcome contributions from all areas of immunology, including molecular immunology, cellular immunology, vaccine engineering, bioinformatics, and public health, encouraging collaboration across disciplines to address complex health challenges.
Scope:
The Journal of Immunology Research and Vaccines publishes original research articles, reviews, clinical trials, and opinion pieces that cover the following topics:
-
Immunology of Infectious Diseases: Research on immune responses to bacterial, viral, fungal, and parasitic infections, as well as new therapeutic approaches for infectious disease management.
-
Vaccine Development and Technology: Studies on novel vaccine platforms, including mRNA, DNA, protein-based, and viral vector vaccines, as well as adjuvants, delivery systems, and stability.
-
Immunotherapy and Immune Modulation: Research on immune-based therapies such as monoclonal antibodies, immune checkpoint inhibitors, CAR-T cell therapy, and immunomodulatory treatments for cancer, autoimmune diseases, and chronic infections.
-
Immunogenetics and Personalized Vaccines: Investigation into the genetic basis of immune responses and the development of personalized or precision vaccines based on individual genetic profiles.
-
Cancer Immunology and Immunotherapy: Studies focused on the immune system’s role in tumorigenesis, tumor immune evasion, and the development of immune-based cancer therapies.
-
Autoimmune and Inflammatory Diseases: Research exploring the immunological basis of autoimmune conditions, including autoimmune diseases, inflammatory disorders, and novel therapeutic strategies.
-
Adjuvants and Delivery Systems: Studies on the development and optimization of adjuvants and vaccine delivery systems to enhance immune response and vaccine efficacy.
-
Global Health and Vaccine Policy: Research addressing the global challenges in vaccination, including vaccine distribution, public health strategies, and policy issues related to vaccination campaigns, vaccine hesitancy, and herd immunity.
-
Immunology in Public Health: Studies that examine the role of vaccines and immunotherapies in the context of public health, global immunization programs, epidemiology, and vaccine safety.
Target Audience:
The Journal of Immunology Research and Vaccines targets an interdisciplinary audience, including:
- Immunologists
- Microbiologists and virologists
- Vaccine developers and biotechnology companies
- Clinical researchers and healthcare professionals
- Public health experts and policymakers
- Pharmaceutical and biotechnology industries
We encourage both basic and applied research, as well as studies that have the potential to impact global health. The journal seeks to bring together a diverse community of experts and foster the exchange of ideas to accelerate progress in the fields of immunology, vaccinology, and immune-based therapies.